# Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction

> **NCT02525081** · PHASE4 · COMPLETED · sponsor: **Bispebjerg Hospital** · enrollment: 63 (actual)

## Conditions studied

- Microvascular Angina

## Interventions

- **DRUG:** Ramipril (ACE-inhibitor)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02525081
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02525081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02525081, "Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02525081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*